A novel framework to assess the prevention value of a health intervention
We propose a value framework that goes beyond traditional health benefit measures to holistically assess chronic disease prevention value. While data limitations prevented the quantification of all shortlisted components, this does not preclude a qualitative discussion of these components in evaluating a preventative intervention. The framework should now be tested with live interventions and key stakeholders to standardise methodologies and enhance future acceptability and use.
Authors
- Manuel Gomes (ORCID: https://orcid.org/0000-0002-1428-1232)
- Ricardo Reynoso (ORCID: https://orcid.org/0000-0002-5468-9582)
- Catrin Treharne
- Jonathan Pearson‐Stuttard (ORCID: https://orcid.org/0000-0003-2175-9975)
- Hugo Harper
- Louis P. Garrison (ORCID: https://orcid.org/0000-0002-9468-4989)
- Irina Pokhilenko (ORCID: https://orcid.org/0000-0001-6390-2851)
- Katherine Byrne
- Jutta Kloppenborg Heick Skau
- Robert P. King
Institutions
- Birmingham City University (GB)
- Novo Nordisk (Denmark) (DK)
- University of Washington (US)
- Novo Nordisk (Switzerland) (CH)
- Nesta (GB)
- Novo Nordisk (United Kingdom) (GB)
- University College London (GB)
- Imperial College London (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1111/dom.70232
- Primary Topic
- Health Promotion and Cardiovascular Prevention
- Type
- article
- Field-Weighted Citation Impact
- 0.00